Skip to main content

Table 2 Comparison between sugammadex and neostigmine groups before and after propensity score-matching. Presented as n (%) or mean (SD)

From: Comparison of the effects of sugammadex and neostigmine on hospital stay in robot-assisted laparoscopic prostatectomy: a retrospective study

 

Before propensity score-matching (n = 1430)

ASD

After propensity score-matching (n = 888)

ASD

Sugammadex

(n = 924)

Neostigmine

(n = 506)

Sugammadex

(n = 444)

Neostigmine

(n = 444)

Age, year (≥65)

579 (62.7)

310 (61.3)

0.03

270 (60.8)

261 (58.8)

0.04

Body mass index, kg m−2

24.5 (2.7)

25.1 (7.7)

0.20

24.7 (2.7)

24.9 (6.2)

0.08

Charlson Comorbidity Index score

4.7 (1.2)

4.8 (1.2)

0.07

4 .8 (1.3)

4.8 (1.2)

0.06

ASA physical status

 1

302 (32.6)

184 (36.4)

 

159 (35.8)

151 (34.0)

 

 2

554 (60.0)

289 (57.1)

0.05

255(57.4)

261 (58.8)

0.03

  ≥ 3

68 (7.4)

33 (6.5)

0.03

30 (6.8)

32 (7.2)

0.02

Intraoperative rocuronium dose, mg

  ≥ 50, and < 100

742 (80.2)

420 (82.8)

0.02

381 (85.8)

383 (86.3)

0.01

  ≥ 100

176 (19.0)

78 (15.4)

0.11

32 (7.2)

39 (8.8)

0.05

Intraoperative remifentanil dose, per 100 mcg (≥10)

76 (8.2)

112 (22.1)

0.52

62(14.0)

59 (13.3)

0.02

Total intravenous anesthesia

68(13.4)

38(4.1)

0.47

35(7.9)

29(6.5)

0.07

Duration of anesthesia, h

3.9 (0.7)

4.2 (0.8)

0.34

4.1 (0.8)

4.1 (0.7)

0.07

Estimated blood loss, L

0.15 (0.1)

0.19 (0.1)

0.25

0.2 (0.2)

0.2 (0.1)

0.08

Distance, kma

  ≥ 40, and < 180

44(8.7)

191(20.7)

0.29

44(9.9)

40(9.0)

0.02

 180≥

20(2.0)

201(21.8)

0.43

20(4.5)

28(6.3)

0.04

Operation by skilled surgeonb

810 (87.6)

407 (80.3)

0.21

367 (82.7)

382 (860.)

0.10

  1. ASA American Society of Anesthesiologists, ASD absolute value of standardized mean difference
  2. Presented as n (%) or mean (standard deviation)
  3. a Distance means the distance between home and the hospital
  4. bSurgeons who had done robot-assisted laparoscopic prostatectomy more than 200 cases